Official Title
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Phase
N/ALead Sponsor
Baylor UniversityStudy Type
InterventionalStatus
WithdrawnIndication/Condition
Parkinson's DiseaseIntervention/Treatment
acamprosate ...Study Participants
0The purpose of this study is to determine how many patients with Parkinson's disease have compulsive behaviors, and what types of behaviors they have. This study will also determine if acamprosate can be used to treat compulsive behaviors in Parkinson's disease patients.
333 mg 2 tabs tid
Inclusion Criteria: Idiopathic Parkinson's disease Active dopaminergic therapy at stable dose for one month (levodopa or dopamine agonist) Able and willing to complete Rating Scales Presence of one or more compulsive behavior based on responses to Rating Scales (defined as >5 on the SOGS; >17 on the YBOCS-SV and YBOCS-CUV; >1.7 on the SCS for women and >2.1 on the SCS for men; >15 on the YBOCS-BE, >5.5 on the CQ). Written informed consent Inclusion criteria (controls): No significant psychiatric disease Able and willing to complete Rating Scales Written informed consent Exclusion Criteria: No anticipated need for adjustment of medications for Parkinson's disease Current participation in another clinical study History of unstable psychiatric disease (as determined by the Principal Investigator) Women of childbearing age not using appropriate contraceptive methods (oral contraceptives, condoms, surgery)